What is the APLS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Apellis Pharmaceuticals, Inc. (APLS) price will be around $47.46 in the next 2 weeks. This means it will increase by 16.18017135862913 from the last closing price. This prediction may vary from other time period filters for APLS stock.

What can be the highest Possible price of APLS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, APLS can achieve the highest price of $56.64 which is 38.65070569751505 higher than last closing price. This prediction may vary from other time period filters for APLS stock.

What can be the lowest Possible price of APLS stock in next 2 weeks?

As per the forecast and algorithmic analysis, APLS stock price can be as low as $38.75 which is -5.139822405820806 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for APLS stock.

Will APLS stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that APLS stock will gain16.18017135862913 in the next 2 weeks. This prediction may vary from other time period filters for APLS stock.

What is APLS stock last closing price?

Last closing price of APLS stock was $40.85.

What is APLS stock price prediction?

APLS stock price prediction means predicting the future closing prices of APLS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of APLS stock in a certain time period.

How we predict APLS stock future prices?

If you are searching for APLS stock forecast, analysis or price prediction, then you might be wondering what Apellis Pharmaceuticals, Inc. (APLS) will do in the future. Our APLS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This APLS price prediction will likely answer most of your questions.

How frequent we update APLS stock predictions?

We are updating the forecasts for the APLS stock on daily basis.

Is using ML forecasting for APLS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for APLS stock same for all the time periods?

No, the prediction for APLS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Apellis Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$40.851.09%Since 2 Weeks

Predicted Price$47.4616.18%For 2 Weeks

Upper Predicted Price$56.6438.65%For 2 Weeks

Lower Predicted Price$38.75-5.14%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of APLS will rise by +16.18% over the next 2 Weeks and hit $47.46 by Tuesday, April 28, 2026. In that time frame, APLS's share price is expected to range between $38.75 and $56.64.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 28, 2026	38.75	47.46	56.64
Apr 27, 2026	35.83	44.76	54.18
Apr 24, 2026	35.36	44.19	52.83
Apr 23, 2026	38.52	47.77	56.40
Apr 22, 2026	36.41	44.87	53.58
Apr 21, 2026	36.34	44.85	53.28
Apr 20, 2026	33.16	42.15	50.92
Apr 17, 2026	32.58	41.58	50.59
Apr 16, 2026	36.47	45.16	53.76
Apr 15, 2026	33.81	42.27	51.99

APLS shares rose +0.02% in Thursday, April 16, 2026's trading session, rising from a previous close of $40.85 to move at $40.86. The stock demonstrated notable intraday movement (see APLS's key stats for a full breakdown), fluctuating between $40.84 and $40.88, a +0.10% trading range. While recent weeks have seen some volatility, APLS has managed to secure a +1.55% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 4.52M shares changing hands, 1.3M fewer than the previous session. This amounted to $184.80M in total market activity.

Will APLS Continue Its Upward Trend?

According to analyst ratings and projections for APLS, Apellis Pharmaceuticals, Inc. shares are anticipated to increase by +27.87%, potentially reaching $56.64 per share by April 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for APLS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the APLS stock forecast, now is a good time to buy APLS stock because its current trading price is -13.92% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on APLS covering social and institutional perspectives.

APLS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into APLS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 83.03% to 91.89%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 69.70%, suggests strong medium-term momentum. However, the 100-day RSI, at 61.12%, points to growing bullish momentum over the long term. Insights into APLS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Apellis Pharmaceuticals Short-Term Forecasts

APLS Forecast For Next 5 Days

Our algorithm anticipates Apellis Pharmaceuticals (APLS) stock could hit $23.03 by Apr 23, 2026. This represents a -43.63% fall from today's price, following a -11.77% change over the past five days.

APLS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Apellis Pharmaceuticals, Inc. (APLS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $32.17, which would mean a -21.26% decrease from the current price of $40.86. Projections for this period range from a high of $49.88 to a low of $16.13.

APLS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Apellis Pharmaceuticals's price over the next three months point to a drop. APLS stock is expected to peak at $46.76 on Apr 27, 2026 before potentially dipping to $24.03 on Jun 19, 2026. On average, APLS is likely to trade around $34.84 in the coming 90 days.

Apellis Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Apellis Pharmaceuticals (APLS) is expected to trade between $15.52 and $46.76 throughout 2026. This would result in an average price of $31.69, potentially offering investors a -22.43% return from current levels.

Apellis Pharmaceuticals, Inc. Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Apellis Pharmaceuticals, Inc. (APLS) is positioned to show a strong performance in April 2026. The price is predicted to move between $35.86 and $46.76, settling at an average of $40.83. This could translate to a -0.06% loss.

May 2026

Based on current market signals, Apellis Pharmaceuticals, Inc. is projected to trend may 2026. We forecast a trading range from $31.12 to $44.88, with a likely average price of $37.66. Investors could expect a potential return of -7.82%.

June 2026

Our predictive algorithms indicate Apellis Pharmaceuticals, Inc. stock may see a shift in June 2026. The expected range spans $24.03–$36.78, with an average target of $30.77. This represents a cautious outlook and a possible loss of -24.68%.

July 2026

Analyzing established trends, Apellis Pharmaceuticals, Inc. looks set to move in July 2026. Projections place the stock between $26.24 and $39.73, averaging around $33.08. This suggests a -19.03% loss from current levels.

August 2026

Market indicators suggest Apellis Pharmaceuticals, Inc. could experience notable changes during August 2026. Prices could fluctuate within $29.71 to $40.81, with a midpoint forecast of $35.18. The stock might deliver a -13.89% loss.

September 2026

Forecasting for September 2026, models estimate that Apellis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.28 and $41.18, averaging $34.14. This signals a cautious trajectory with potential returns around -16.44%.

October 2026

According to our latest forecast models, Apellis Pharmaceuticals, Inc. (APLS) is positioned to show a strong performance in October 2026. The price is predicted to move between $16.79 and $36.92, settling at an average of $29.09. This could translate to a -28.80% loss.

November 2026

Based on current market signals, Apellis Pharmaceuticals, Inc. is projected to trend november 2026. We forecast a trading range from $15.52 to $29.56, with a likely average price of $23.20. Investors could expect a potential return of -43.21%.

December 2026

Our predictive algorithms indicate Apellis Pharmaceuticals, Inc. stock may see a shift in December 2026. The expected range spans $19.00–$32.79, with an average target of $26.05. This represents a cautious outlook and a possible loss of -36.24%.

January 2027

Analyzing established trends, Apellis Pharmaceuticals, Inc. looks set to move in January 2027. Projections place the stock between $21.92 and $33.55, averaging around $27.94. This suggests a -31.61% loss from current levels.

February 2027

Market indicators suggest Apellis Pharmaceuticals, Inc. could experience notable changes during February 2027. Prices could fluctuate within $20.15 to $33.77, with a midpoint forecast of $26.68. The stock might deliver a -34.70% loss.

March 2027

Forecasting for March 2027, models estimate that Apellis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.41 and $29.80, averaging $21.89. This signals a cautious trajectory with potential returns around -46.42%.

April 2027

According to our latest forecast models, Apellis Pharmaceuticals, Inc. (APLS) is positioned to show a strong performance in April 2027. The price is predicted to move between $9.06 and $22.05, settling at an average of $15.90. This could translate to a -61.08% loss.

APLS's history of dividends and stock splits also plays a role in long-term investor confidence.